Ophthalmology Research Capabilities Added to New Site Near WCCT Global’s Clinical Pharmacology Units
COSTA MESA, Calif., September 20, 2013/PRWeb/–WCCT Global, a Southern California headquartered, full service CRO, announces today that they can now provide expanded support and services in clinical ophthalmology research for medicine and science. These new ophthalmic research services are in addition to the diverse clinical services our sponsors have enjoyed for several years. This acquisition of OC Clinical Trials & Consulting will provide research capabilities spanning glaucoma, oculoplastics, cosmetic clinical research, cornea & external ocular disease, and pediatric ophthalmic conditions at 2 sites in Tustin, CA.
This acquisition supports WCCT Global’s vision to offer innovative service options to their clients in the form of designated research and patient care specialty facilities for both early and late phase clinical research spanning multiple specialty therapeutic areas. This new ophthalmology research facility is also in close proximity to WCCT Global’s multiple Southern California based clinical pharmacology units located in Orange County, CA. Having the 5 clinical research facilities within minutes of each other provides sponsors the ability and convenience of visiting each location during any single visit to California. WCCT Global’s Chief Operating Officer Jon Rojas stated, “The strategic placement of each of our 5 California research facilities offering unique therapeutic research services enables WCCT Global to provide both patient access and expert therapeutic knowledge and experience for each clinical study that we carry out on behalf of our Sponsors.”